India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

Bliss GVS Pharma Ltd.

Income Statement - Consolidated

Market Cap.(`)	1682.26 Cr.	P/BV	1.74	Book Value (`)	91.83
52 Week High/Low ( ` )	150/92	FV/ML	1/1	P/E(X)	22.30
Book Closure	25/07/2024	EPS (`)	7.16	Div Yield (%)	0.31

(` in Crs.)

You can view the Consolidated Income Statement for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00


INCOME
Revenue From Operations [Net]	765.91	747.43	737.93	568.69	681.91
Other Operating Revenues	4.34	4.16	9.53	8.52	7.40
Total Operating Revenues	770.24	751.59	747.45	577.21	689.31

Other Income	28.74	17.79	31.49	20.22	39.19
Total Revenue	798.98	769.37	778.95	597.43	728.49

EXPENSES
Cost Of Materials Consumed	339.12	330.04	385.27	259.81	260.00
Purchase Of Stock-In Trade	51.35	44.34	34.91	80.98	175.67
Changes In Inventories Of FG,WIP And Stock-In Trade	-8.35	26.94	-29.20	-11.88	4.30
Employee Benefit Expenses	95.58	86.17	76.15	68.09	53.69
Finance Costs	6.91	10.36	4.74	5.51	7.57
Depreciation And Amortisation Expenses	26.38	18.67	17.33	17.23	12.59
Other Expenses	141.92	146.77	161.98	73.56	72.33
Total Expenses	652.91	663.30	651.19	493.30	586.15

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	146.07	106.07	127.76	104.13	142.35

Exceptional Items	-29.20	0.00	-73.59	0.00	-13.38
Profit/Loss Before Tax	116.87	106.07	54.17	104.13	128.97

Tax Expenses-Continued Operations
Current Tax	32.40	40.75	39.14	26.04	36.73
Deferred Tax	2.03	-11.51	-4.74	1.23	-3.09
Tax For Earlier Years	0.86	0.09	-3.35	2.88	0.08
Total Tax Expenses	35.29	29.34	31.04	30.16	33.71
Profit/Loss After Tax And Before ExtraOrdinary Items	81.58	76.73	23.13	73.97	95.25

Profit/Loss From Continuing Operations	81.58	76.73	23.13	73.97	95.25

Profit/Loss For The Period	81.58	76.73	23.13	73.97	95.25

Minority Interest	-6.12	-5.88	-8.09	-5.48	2.01
Consolidated Profit/Loss After MI And Associates	75.45	70.86	15.04	68.49	97.27

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	7.23	6.83	1.46	6.64	9.43
Diluted EPS (Rs.)	7.11	6.72	1.43	6.49	9.43

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	5.21	5.19	5.18	5.16	12.43

Bliss GVS Pharma Ltd.

Balance Sheet - Consolidated

Market Cap.(`)	1682.26 Cr.	P/BV	1.74	Book Value (`)	91.83
52 Week High/Low ( ` )	150/92	FV/ML	1/1	P/E(X)	22.30
Book Closure	25/07/2024	EPS (`)	7.16	Div Yield (%)	0.31

(` in Crs.)

You can view the Consolidated Balance Sheet for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00
No. of Equity Shares (in Lacs)	1046.91	1041.53	0.00	1031.47	1031.47

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	10.47	10.42	10.37	10.31	10.31
Total Share Capital	10.47	10.42	10.37	10.31	10.31

Reserves and Surplus	956.72	873.48	798.40	788.10	725.30
Total Reserves and Surplus	956.72	873.48	798.40	788.10	725.30
Employees Stock Options	0.00	0.00	9.94	9.84	0.00
Total Shareholders Funds	967.19	883.90	818.70	808.25	735.61
Minority Interest	35.79	33.53	27.76	19.66	14.76

NON-CURRENT LIABILITIES
Long Term Borrowings	35.59	40.69	23.22	32.60	37.24
Deferred Tax Liabilities [Net]	3.59	0.00	1.32	8.21	3.55
Other Long Term Liabilities	9.34	2.79	3.58	1.93	3.23
Long Term Provisions	2.54	2.69	1.07	2.50	2.44
Total Non-Current Liabilities	51.06	46.17	29.20	45.24	46.47

CURRENT LIABILITIES
Short Term Borrowings	52.21	57.38	81.74	65.04	66.39
Trade Payables	60.97	86.39	92.61	74.22	94.15
Other Current Liabilities	46.64	46.15	52.03	55.71	58.22
Short Term Provisions	0.00	3.34	6.72	8.66	13.43
Total Current Liabilities	159.82	193.26	233.09	203.64	232.18

Total Capital And Liabilities	1213.87	1156.85	1108.75	1076.79	1029.02

ASSETS
NON-CURRENT ASSETS
Tangible Assets	362.24	370.80	273.36	226.12	233.31
Intangible Assets	0.11	0.23	0.38	0.58	0.64
Capital Work-In-Progress	7.83	2.80	22.15	2.39	0.00
Fixed Assets	370.17	373.83	295.89	229.09	233.95
Goodwill On Consolidation	7.71	7.71	7.71	7.71	7.71
Non-Current Investments	3.61	2.84	2.39	0.01	0.02
Deferred Tax Assets [Net]	0.00	3.33	0.00	0.00	0.00
Long Term Loans And Advances	0.00	0.00	0.00	2.10	1.90
Other Non-Current Assets	20.75	71.78	26.72	72.67	12.49
Total Non-Current Assets	402.25	459.49	332.71	311.59	256.07


CURRENT ASSETS
Current Investments	0.56	4.96	0.00	0.00	0.00
Inventories	118.45	103.06	123.94	98.93	74.14
Trade Receivables	404.35	385.17	392.75	463.82	547.91
Cash And Cash Equivalents	215.62	102.99	177.53	144.55	103.32
Short Term Loans And Advances	0.07	0.10	0.13	0.16	0.17
OtherCurrentAssets	72.58	101.09	81.69	57.75	47.41
Total Current Assets	811.62	697.37	776.03	765.20	772.95

Total Assets	1213.87	1156.85	1108.75	1076.79	1029.02

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	56.89	11.59	22.70	30.31	14.33

BONUS DETAILS
Bonus Equity Share Capital	4.91	4.91	4.91	4.91	4.91

NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.51	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	3.61	2.33	2.39	0.01	0.02

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : [email protected] | For any DP Grievance mail to : [email protected]. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

Bliss GVS Pharma Ltd.

Income Statement - Consolidated

Bliss GVS Pharma Ltd.

Balance Sheet - Consolidated